<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="132781">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01873378</url>
  </required_header>
  <id_info>
    <org_study_id>GnRHa hysteroscopic myomectomy</org_study_id>
    <nct_id>NCT01873378</nct_id>
  </id_info>
  <brief_title>GnRH Agonist Pretreatment in Hysteroscopic Myomectomy</brief_title>
  <official_title>Surgical Effects of GnRH Agonist Pretreatment on Cold Loop Hysteroscopic Myomectomy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera S. Maria della Misericordia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera S. Maria della Misericordia</source>
  <oversight_info>
    <authority>Italy: National Monitoring Centre for Clinical Trials - Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether GnRH agonist treatment before cold loop
      hysteroscopic myomectomy is effective in reducing operative time, fuid absorption and
      difficulty of the procedure.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Minutes (surgical procedure time), milliliters (fluid absorption during the procedure), 0-3 scale (difficulty of the procedure), 0-3 scale (quality of image)</measure>
    <time_frame>5 minutes after the end of the surgical procedure.</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Uterine Myoma</condition>
  <arm_group>
    <arm_group_label>GnRH agonist pretreatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>triptorelin 3.75 mg, im, monthly, three times</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No pharmacological treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triptorelin 3.75 mg</intervention_name>
    <arm_group_label>GnRH agonist pretreatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  submucous myoma diagnosed by vaginal ultrasonography and confirmed by diagnostic
             hysteroscopy

          -  premenopausal status

        Exclusion Criteria:

          -  present or past history of cancer

          -  pregnancy

          -  presence of associated multiple polyps

          -  presence of &gt; 2 myomas

          -  associated nonhysteroscopic surgical procedures
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>sandro gerli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Perugia, Perugia, Italy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sandro Gerli, MD</last_name>
    <phone>368434624</phone>
    <phone_ext>+39</phone_ext>
    <email>gerber@unipg.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alessandro Favilli, MD</last_name>
    <phone>3292270705</phone>
    <phone_ext>+39</phone_ext>
    <email>alessandrofavilli.mail@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Arbor Vitae Endoscopic Centre</name>
      <address>
        <city>Rome</city>
        <zip>00191</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ivan Mazzon, MD</last_name>
      <email>i.mazzon@arborvitae.it</email>
    </contact>
    <investigator>
      <last_name>Ivan Mazzon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 8, 2013</lastchanged_date>
  <firstreceived_date>June 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera S. Maria della Misericordia</investigator_affiliation>
    <investigator_full_name>Sandro Gerli</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Uterine myoma</keyword>
  <keyword>GnRHa</keyword>
  <keyword>Hysteroscopy</keyword>
  <keyword>Cold loop</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Myoma</mesh_term>
    <mesh_term>Leiomyoma</mesh_term>
    <mesh_term>Myofibroma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Triptorelin</mesh_term>
    <mesh_term>Deslorelin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
